Abingdon Health Statistics

Total Valuation

Abingdon Health has a market cap or net worth of GBP 21.62 million. The enterprise value is 18.95 million.

Market Cap	21.62M
Enterprise Value	18.95M

Important Dates

The next estimated earnings date is Friday, June 20, 2025.

Earnings Date	Jun 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Abingdon Health has 375.95 million shares outstanding. The number of shares has increased by 8.55% in one year.

Current Share Class	n/a
Shares Outstanding	375.95M
Shares Change (YoY)	+8.55%
Shares Change (QoQ)	+16.11%
Owned by Insiders (%)	7.23%
Owned by Institutions (%)	36.77%
Float	135.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.17
PB Ratio	3.37
P/TBV Ratio	6.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.33
EV / Sales	2.78
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.08

Financial Position

The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.16.

Current Ratio	2.55
Quick Ratio	2.36
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-0.38
Interest Coverage	-39.55

Financial Efficiency

Return on equity (ROE) is -62.83% and return on invested capital (ROIC) is -28.93%.

Return on Equity (ROE)	-62.83%
Return on Assets (ROA)	-20.26%
Return on Invested Capital (ROIC)	-28.93%
Return on Capital Employed (ROCE)	-32.09%
Revenue Per Employee	60,345
Profits Per Employee	-22,894
Employee Count	84
Asset Turnover	0.93
Inventory Turnover	7.56

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.24% in the last 52 weeks. The beta is 0.20, so Abingdon Health's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	-45.24%
50-Day Moving Average	6.87
200-Day Moving Average	8.34
Relative Strength Index (RSI)	30.43
Average Volume (20 Days)	228,040

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Abingdon Health had revenue of GBP 6.82 million and -2.59 million in losses. Loss per share was -0.01.

Revenue	6.82M
Gross Profit	3.59M
Operating Income	-2.37M
Pretax Income	-2.81M
Net Income	-2.59M
EBITDA	-2.03M
EBIT	-2.37M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 3.67 million in cash and 1.01 million in debt, giving a net cash position of 2.66 million or 0.01 per share.

Cash & Cash Equivalents	3.67M
Total Debt	1.01M
Net Cash	2.66M
Net Cash Per Share	0.01
Equity (Book Value)	6.42M
Book Value Per Share	0.02
Working Capital	3.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.65 million and capital expenditures -23,000, giving a free cash flow of -2.68 million.

Operating Cash Flow	-2.65M
Capital Expenditures	-23,000
Free Cash Flow	-2.68M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 52.57%, with operating and profit margins of -34.80% and -37.94%.

Gross Margin	52.57%
Operating Margin	-34.80%
Pretax Margin	-41.24%
Profit Margin	-37.94%
EBITDA Margin	-29.83%
EBIT Margin	-34.80%
FCF Margin	n/a

Dividends & Yields

Abingdon Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.55%
Shareholder Yield	-8.55%
Earnings Yield	-11.97%
FCF Yield	-12.38%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Abingdon Health has an Altman Z-Score of 1.46. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.46
Piotroski F-Score	n/a